[Federal Register Volume 84, Number 226 (Friday, November 22, 2019)]
[Notices]
[Pages 64562-64563]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25403]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-528]


Importer of Controlled Substances Application: Fresenius Kabi 
USA, LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before December 23, 2019. 
Such persons may also file a written request for a hearing on the 
application on or before December 23, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on August 7, 2019 Fresenius Kabi USA, LLC, 3159 Staley 
Road, Grand Island, New York 14072-

[[Page 64563]]

2028 applied to be registered as an importer of the following basic 
classes of controlled substances:

------------------------------------------------------------------------
         Controlled substance              Drug code         Schedule
------------------------------------------------------------------------
Remifentanil..........................            9739               II
------------------------------------------------------------------------

    The company plans to import the listed controlled substance for 
bulk manufacture.

    Dated: October 23, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019-25403 Filed 11-21-19; 8:45 am]
BILLING CODE 4410-09-P